Submit an abstract for the Spotlight on Immuno-Oncology conference by June 2, 11:59 p.m. PT
The ASGCT Board of Directors and the Society's Officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws.
Learn More
ASGCT's mission and vision statements determine the goals and philosophy of the organization.
Learn about the history of ASGCT from Society founder George Stamatoyannopoulos in an interview from the 20th Annual Meeting.
The strategic plan includes input from ASGCT membership, opinion leaders in gene and cell therapy, Society leadership, and Society staff members.
Meet the American Society of Gene and Cell Therapy staff.
ASGCT's 20 scientific commitees and 16 standing commitees determine many of the Society's activities.
Read the full governing bylaws of the American Society of Gene & Cell Therapy, which were amended and restated in April, 2017.
Read ASGCT's conflict of interest policy for U.S. public health service-supported programs.
May 16-20 | Los Angeles, CA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico